Swiss Ministers Meet With Roche, Novartis Amid Tariff Crisis

The Swiss government met with executives of Roche Holding AG and Novartis AG to discuss the pharmaceutical industry’s situation in light of US tariffs.

Switzerland was hit with a 39% tariff rate by the US this month, far higher than the 15% levied on the neighboring European Union. Pharmaceuticals are currently exempt from Donald Trump’s tariffs, but that might soon change, with the president warning he could announce measures on the sector.

Read more: From Hope to Despair: How Switzerland’s Tariff Drama Played Out

Swiss Interior Minister Elisabeth Baume-Schneider and Economy Minister Guy Parmelin met Thursday morning with Roche ...